Thrombolysis in pulmonary embolism - Status 2004;Thrombolyse bei lungenembolie - Status 2004

Journal fur Kardiologie

Volumn 11, Issue 12, 2004, Pages 497-502

  Hief, C ^a   Geppert, A ^a   Haoula, D ^a   Koch, J ^a   Huber, Kurt ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; STREPTOKINASE; TENECTEPLASE; TROPONIN; UROKINASE;

ALGORITHM; ANTICOAGULATION; BLOOD CLOT LYSIS; DISEASE SEVERITY; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART VENTRICLE FUNCTION; HEMODYNAMIC MONITORING; HUMAN; LUNG EMBOLISM; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 10344246620     PISSN: 10240098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17: 259-70.
2. Morrell MT, Dunnill MS. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968; 55: 347-52.
3. Karwinsky B. Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Path 1989; 42: 135-9.
4. Goldhaber Sz, Hennekens CH, Evans DA, Newton EC, Godleski JJ. Factors associated with correct ante mortem diagnosis of major pulmonary embolism. Am J Med 1982; 73: 822-6.
5. Goldberger SZ. Thrombolysis in pulmonary embolism: large-scale clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet 1999; 353: 1386-9.
6. Ferrari E, Baudouny M, Cerboni P, Tibi T, Guigner A, Leonetti J, Bory M, Morano P. Clinical epidemiology of venous thromboembolic disease: results of a French multicentre registry. Eur Heart J 1997; 18: 685-91.
7. Sìmonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, Laurent M, Hirsch JL, Ferrari E, Bosson JL, Mottier D, Beau B for the THESEE study group. THESEE Study group: A comparison of low-molecular-weight heparin with unfractionated Heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-9.
8. Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 357-62.
9. van Beek EJR, Kuijer PMM, Buller HR, Brandjes DP, Bossuyt PM, ten Cate JW. The clinical course of patients with suspected pulmonary embolism. Arch Intern Med 1997; 157: 2593-8.
10. Goldhaber SZ, Visani L. The international cooperative pulmonary embolism registry. Chest 1995; 108: 302-4.
11. Sharma GVRK, Burleson VA, Sasahara AA. Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. N Engl J Med 1980; 303: 842-5.
12. Tibbutt DA, Davies JA, Andersen JA, Fletcher EW, Hamill J, Holt JM, Thomas ML, Lee G, Miller GA, Sharp AA, Sutton GC. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Br Med J 1974; 1: 343-7.
13. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators. Chest 1990; 97: 528-33.
14. Urokinase Pulmonary Embolism Trial: phase 1 result - a cooperative study. J Am Med Assoc 1970; 214: 2163-71.
15. Ly B, Arnesen H, Erie H, Ly B, Arnesen H, Eie H, Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med A Scand 1978; 203: 465-70.
16. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira da Silva AM. Come PC, Lee RT, Parker JA. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-11.
17. Jerjes-Sanchez C, Ramirez-Rivera A, Garcia M de L, Arriaga-Naya R, Valencia S, Rosaoo-Busso A, Pierzo JA, Rosas E. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 1995; 2: 227-9.
18. Konstantinides S. Geibel A, Heusel G, Heinrch F, Kasper W, for the management and prognosis of pulmonary embolism - 3 trial investigation. Heparin plus Alteplase compared with Heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-50.
19. Levine M, Hirsh J, Weitz J Cruickshank M, Neemeh J, Turpie AG, Gent M. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990; 98: 1473-9.
20. Dalen JE, Banas JS, Brooks HL, Evans GL, Paraskos JA, Dexter L. Resolution rate of acute pulmonary embolism in man. N Engl J Med 1969; 280: 1194-9.
21. Tow DE, Wagner NHJ. Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 1967; 276: 1053-9.
22. Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visiolo O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multicentre Study 2. J Am Coll Cardiol 1992; 20: 520-6.
23. Kasper W, Konstantinides S, Geibel A, Tiede N, Krause T, Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77: 246-9.
24. Ribeiro A, Lindmaker P, Juhlin-Dannefeldt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134: 479-87.
25. Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G, Berni G, Short term clinical outcome of patients with acute pulmonary embolism, normal blood pressure and echocardiography right ventricular dysfunction. Circulation 2000; 101: 2817-22.
26. Vieillard-Baron A, Page B, Augarde R, Prin S, Qanadi S, Beauchet A, Dubourg D, Jardin F. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27: 1481-6.
27. Giannitsis E. Müller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, Katus H. Independent prognostic value of cardiac Troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-7.
28. Konstantinides ST, Geibel A, Olschewski M, Kasper W, Hruska N, Jäckle S, Binder L. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-8.
29. Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, Iversens S, Redecker M, Kienast J, Just H, Kasper W. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation 1997; 96: 882-8.
30. Wolfe MW, Lee RT, Feldstein ML, Parker JA, Come PC, Goldhaber SZ. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J 1994; 127: 1371-5.
31. Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, Iversen S, Radecker M, Kiensat J. Management strategies and determinations of outcomes in acute major pulmonary embolism: results of a multicentre registry. J Am Coll Cardiol 1997; 30: 1165-71.
32. Dalen JE, Alpert JS, Hirsch J. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med 1997; 157: 2550-6.
33. Levine MN. Thrombolytic therapy for venous thromboembolism: complications and contraindications. Clin Chest Med 1995; 16: 321-8.
34. van de Werf F. Single-bolus Tenecteplase compared with front-loaded Alteplase in acute myocardial infarction: the ASSENT-2 double blind randomized trial. Lancet 1999; 354: 716-22.
35. Daniels LB, Parker JA, Patel SR. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 1997; 80: 184-8.
36. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-36.
37. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470-84.
38. Pengo V, Lensing A, Prins M, Marchiori A, Davidson B, Tiozzo F, Albanese P, Biasiolo A, Pegoraro S, Prandoni P. Incidence of chronic Thromboembolic pulmonary Hypertension after Pulmonary Embolism. N Engl J Med 2004; 350: 2257-64.